► Subscribe to the Financial Times on YouTube: http://bit.ly/FTimeSubs
AstraZeneca has won extended US approval for a pipeline drug but, as Lex's Oliver Ralph and Robert Armstrong discuss, it needs more good news to stem its patent expiration problem.
For more video content from the Financial Times, visit http://www.FT.com/video
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes
